Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
This distinction between true value and value traps can challenge even the most skilled investors. Luckily for you, we started StockStory to help you uncover exceptional companies. Keeping that in mind, here are three value stocks with little support and some other investments you should consider instead.
Sirius XM (SIRI)
Forward P/E Ratio: 7.2x
Known for its commercial-free music channels, Sirius XM (NASDAQ: SIRI) is a broadcasting company that provides satellite radio and online radio services across North America.
Why Is SIRI Risky?
- Demand for its offerings was relatively low as its number of core subscribers has underwhelmed
- Projected sales for the next 12 months are flat and suggest demand will be subdued
- Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results
Sirius XM is trading at $21.66 per share, or 7.2x forward P/E. Read our free research report to see why you should think twice about including SIRI in your portfolio.
Sealed Air (SEE)
Forward P/E Ratio: 11.4x
Founded in 1960, Sealed Air Corporation (NYSE: SEE) specializes in the development and production of protective and food packaging solutions, serving a variety of industries.
Why Do We Think SEE Will Underperform?
- Flat unit sales over the past two years suggest it might have to lower prices to accelerate growth
- Demand will likely be weak over the next 12 months as Wall Street expects flat revenue
- Waning returns on capital imply its previous profit engines are losing steam
Sealed Air’s stock price of $36.80 implies a valuation ratio of 11.4x forward P/E. Dive into our free research report to see why there are better opportunities than SEE.
Pfizer (PFE)
Forward P/E Ratio: 7.9x
With roots dating back to 1849 when two German immigrants opened a fine chemicals business in Brooklyn, Pfizer (NYSE: PFE) is a global biopharmaceutical company that discovers, develops, manufactures, and sells medicines and vaccines for a wide range of diseases and conditions.
Why Are We Cautious About PFE?
- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
- Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 26.5 percentage points
- Diminishing returns on capital suggest its earlier profit pools are drying up
At $24.73 per share, Pfizer trades at 7.9x forward P/E. If you’re considering PFE for your portfolio, see our FREE research report to learn more.
Stocks We Like More
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
